BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10917201)

  • 21. Prostate specific antigen gene expression in androgen insensitive prostate carcinoma subculture cell line.
    Tsui KH; Feng TH; Chung LC; Chao CH; Chang PL; Juang HH
    Anticancer Res; 2008; 28(4A):1969-76. PubMed ID: 18649734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanoparticulate delivery of suicide DNA to murine prostate and prostate tumors.
    Peng W; Anderson DG; Bao Y; Padera RF; Langer R; Sawicki JA
    Prostate; 2007 Jun; 67(8):855-62. PubMed ID: 17427200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgen-dependent gene expression of prostate-specific antigen is enhanced synergistically by hypoxia in human prostate cancer cells.
    Horii K; Suzuki Y; Kondo Y; Akimoto M; Nishimura T; Yamabe Y; Sakaue M; Sano T; Kitagawa T; Himeno S; Imura N; Hara S
    Mol Cancer Res; 2007 Apr; 5(4):383-91. PubMed ID: 17426252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenovirus-mediated tissue-targeted expression of a caspase-9-based artificial death switch for the treatment of prostate cancer.
    Xie X; Zhao X; Liu Y; Zhang J; Matusik RJ; Slawin KM; Spencer DM
    Cancer Res; 2001 Sep; 61(18):6795-804. PubMed ID: 11559553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate-tumor targeting of gene expression by lentiviral vectors containing elements of the probasin promoter.
    Yu D; Jia WW; Gleave ME; Nelson CC; Rennie PS
    Prostate; 2004 Jun; 59(4):370-82. PubMed ID: 15065085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcription-targeted gene therapy for androgen-independent prostate cancer.
    Martiniello-Wilks R; Tsatralis T; Russell P; Brookes DE; Zandvliet D; Lockett LJ; Both GW; Molloy PL; Russell PJ
    Cancer Gene Ther; 2002 May; 9(5):443-52. PubMed ID: 11961667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting and killing of prostate cancer cells using lentiviral constructs containing a sequence recognized by translation factor eIF4E and a prostate-specific promoter.
    Yu D; Scott C; Jia WW; De Benedetti A; Williams BJ; Fazli L; Wen Y; Gleave M; Nelson C; Rennie PS
    Cancer Gene Ther; 2006 Jan; 13(1):32-43. PubMed ID: 16052226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors.
    Wu L; Matherly J; Smallwood A; Adams JY; Billick E; Belldegrun A; Carey M
    Gene Ther; 2001 Sep; 8(18):1416-26. PubMed ID: 11571582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model.
    Gabril MY; Onita T; Ji PG; Sakai H; Chan FL; Koropatnick J; Chin JL; Moussa M; Xuan JW
    Gene Ther; 2002 Dec; 9(23):1589-99. PubMed ID: 12424611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
    Igawa T; Lin FF; Rao P; Lin MF
    Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human osteocalcin: a strong promoter for nitric oxide synthase gene therapy, with specificity for hormone refractory prostate cancer.
    McCarthy HO; Coulter JA; Worthington J; Robson T; Hirst DG
    J Gene Med; 2007 Jun; 9(6):511-20. PubMed ID: 17471586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus-based vector improves the tumor cell killing effect of pituitary tumor in HVJ-liposome-mediated transcriptional targeting suicide gene therapy.
    Izumo T; Ohtsuru A; Tokunaga Y; Namba H; Kaneda Y; Nagata I; Yamashita S
    Int J Oncol; 2007 Aug; 31(2):379-87. PubMed ID: 17611695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter.
    Tanaka S; Iwai M; Harada Y; Morikawa T; Muramatsu A; Mori T; Okanoue T; Kashima K; Maruyama-Tabata H; Hirai H; Satoh E; Imanishi J; Mazda O
    Cancer Gene Ther; 2000 Sep; 7(9):1241-50. PubMed ID: 11023196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-specific expression of the diphtheria toxin A-chain coding sequence induces cancer cell suicide.
    Rui H; Chen Y
    Chin Med J (Engl); 2002 Jun; 115(6):869-73. PubMed ID: 12123555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of the PSA enhancer core element to modulate the expression of prostate- and non-prostate-specific basal promoters in a lentiviral vector context.
    Chapel-Fernandes S; Jordier F; Lauro F; Maitland N; Chiaroni J; de Micco P; Mannoni P; Bagnis C
    Cancer Gene Ther; 2006 Oct; 13(10):919-29. PubMed ID: 16741521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In situ prostate cancer gene therapy using a novel adenoviral vector regulated by the caveolin-1 promoter.
    Pramudji C; Shimura S; Ebara S; Yang G; Wang J; Ren C; Yuan Y; Tahir SA; Timme TL; Thompson TC
    Clin Cancer Res; 2001 Dec; 7(12):4272-9. PubMed ID: 11751529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
    Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly specific expression of luciferase gene in lungs of naïve nude mice directed by prostate-specific antigen promoter.
    Li HW; Li J; Helm GA; Pan D
    Biochem Biophys Res Commun; 2005 Sep; 334(4):1287-91. PubMed ID: 16043123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
    Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
    Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenovirus-mediated transfer of inducible caspases: a novel "death switch" gene therapeutic approach to prostate cancer.
    Shariat SF; Desai S; Song W; Khan T; Zhao J; Nguyen C; Foster BA; Greenberg N; Spencer DM; Slawin KM
    Cancer Res; 2001 Mar; 61(6):2562-71. PubMed ID: 11289132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.